Inventor · disambiguated record
Stuart J. Madden
Also filed as: MADDEN STUART · MADDEN STUART J
7 granted patents·8 pending applications·23 citations·filing 2009–2025
82Inventor score
Top patents by PatentIndex Score
15 records- 0195US11813231B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2021·Granted Nov 14, 2023·5 cites·20 claims
- 0295US11628150B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2020·Granted Apr 18, 2023·5 cites·30 claims
- 0387US11020361B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2018·Granted Jun 1, 2021·5 cites·17 claims
- 0480US8334281B2Nasal formulations of metoclopramideD ONOFRIO MATTHEW J·Filed 2009·Granted Dec 18, 2012·8 cites·29 claims
- 0580US2025228803A1Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2024·Application pending·0 cites
- 0677US12194009B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2021·Granted Jan 14, 2025·0 cites·14 claims
- 0777US12194008B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2021·Granted Jan 14, 2025·0 cites·17 claims
- 0874US2025302741A1Intranasal olanzapine formulations and methods of their useNEURELIS INC·Filed 2024·Application pending·0 cites
- 0973US12171868B2Intranasal olanzapine formulations and methods of their useNEURELIS INC·Filed 2023·Granted Dec 24, 2024·0 cites·30 claims
- 1063US2017071885A1Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2016·Application pending·0 cites
- 1163US2022218598A1Methods and compositions for rapid delivery of anti-seizure therapeuticsNEURELIS INC·Filed 2022·Application pending·0 cites
- 1262US2023399311A1Polymorphs of substituted isoquinoline-based rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1349US2013213393A1Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2012·Application pending·0 cites
- 1445US2025281479A1Treatment of cavernous angiomas with a 4-substituted piperidine derivativeNEURELIS INC·Filed 2025·Application pending·0 cites
- 1544US2025352554A1Intranasal olanzapine formulations and methods of their useNEURELIS INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →